Cancer Talk

Tuesday, April 10, 2012 - 12:32pm

On April 8, 1987, the U.S. House of Representatives’ Joint Resolution 119 designated the third week in April as National Minority Cancer Awareness Week.

Since then, groups across the country have used the week to draw attention to the unfortunate reality that certain subgroups of our population are disproportionately impacted by cancer.

We refer to these differences, or inequities, as “cancer health disparities.”

Tuesday, March 27, 2012 - 12:19pm

Multiple Myeloma is the second most common type of hematologic cancer, or cancer found in the cells of blood or bone marrow. Because March is National Myeloma Awareness Month, I’d like to take this opportunity to share some basic information about the disease.

Thursday, March 22, 2012 - 12:28pm

March is National Nutrition Month. We all know our eating habits have a definitive impact on our overall health. For cancer patients, nutrition is especially important as it plays an essential role in the healing and recovery process.

Friday, March 16, 2012 - 4:05pm

A diagnosis of cancer changes your life, and the lives of those closest to you, forever. It impacts you physically, emotionally, socially … every way imaginable.

Thursday, March 1, 2012 - 2:23pm

March is Colorectal Cancer Awareness Month. It’s the perfect opportunity to find out what you should know about colorectal cancer, the third most common type of cancer in men and women.

Thursday, March 1, 2012 - 10:59am

Scott knows all too well the consequences of using indoor tanning beds.

He has the scar to prove it.

Tuesday, February 28, 2012 - 9:48am

As a cancer patient, you may never see a flow cytometer at Roswell Park, but, behind the scenes, this analytical tool plays a vital role in the diagnosis, classification and management of many cancers.

Wednesday, February 15, 2012 - 4:08pm

Roswell Park Comprehensive Cancer Center recently announced a new clinical trial of a cancer vaccine. Dr.

Tuesday, February 14, 2012 - 3:24pm

By studying the effects of bevacizumab (brand name AvastinTM), a drug currently FDA-approved for use in the treatment of several other cancers, a research team led by the Gynecologic Oncology Group (GOG)  has laid the groundwork for a possible new trea